1. A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial. (November 2020) Authors: Dhruva, Anand; Wu, Cairn; Miaskowski, Christine; Hartogensis, Wendy; Rugo, Hope S; Adler, Shelley R; Kaptchuk, Ted J; Kelkar, Rucha; Agarawal, Sangeeta; Vadodaria, Amisha; Garris, Ellen; Hecht, Frederick M Journal: Global advances in health and medicine Issue: Volume 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika... Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Issue 4 (April 2018) Authors: Loibl, Sibylle; O'Shaughnessy, Joyce; Untch, Michael; Sikov, William M; Rugo, Hope S; McKee, Mark D; Huober, Jens; Golshan, Mehra; von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark, Norman; McIntyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto; Rastogi, Priya; Symmans, W Fras... Journal: Lancet oncology Issue: Volume 19:Issue 4(2018) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Issue 3 (March 2023) Authors: Tolaney, Sara M; Tarantino, Paolo; Graham, Noah; Tayob, Nabihah; Parè, Laia; Villacampa, Guillermo; Dang, Chau T; Yardley, Denise A; Moy, Beverly; Marcom, P Kelly; Albain, Kathy S; Rugo, Hope S; Ellis, Matthew J; Shapira, Iuliana; Wolff, Antonio C; Carey, Lisa A; Barroso-Sousa, Romualdo; Villagra... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Issue 4 (April 2021) Authors: Rugo, Hope S; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-Ming; Turner, Stuart; Kanakamedala, Hemanth; H... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes. Issue 4 (1st August 2019) Authors: Uno, Hajime; Schrag, Deborah; Kim, Dae Hyun; Tang, Dejun; Tian, Lu; Rugo, Hope S; Wei, Lee-Jen Journal: JNCI cancer spectrum Issue: Volume 3:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. (1st February 2021) Authors: Emens, Leisha A; Molinero, Luciana; Loi, Sherene; Rugo, Hope S; Schneeweiss, Andreas; Diéras, Véronique; Iwata, Hiroji; Barrios, Carlos H; Nechaeva, Marina; Nguyen-Duc, Anh; Chui, Stephen Y; Husain, Amreen; Winer, Eric P; Adams, Sylvia; Schmid, Peter Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 8(2021) Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2020) Authors: Schmid, Peter; Rugo, Hope S; Adams, Sylvia; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Diéras, Véronique; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y; Maiya, Vidya; Husain, Amreen; Winer, Eric P; Loi, Sherene; Emens, Leisha A Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Demystifying biosimilars: development, regulation and clinical use. (30th November 2018) Authors: Rugo, Hope S; Rifkin, Robert M; Declerck, Paul; Bair, Angel H; Morgan, Geraint Journal: Future oncology Issue: Volume 15:Number 7(2019) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial. Issue 15 (November 2015) Authors: Perez, Edith A; Awada, Ahmad; O'Shaughnessy, Joyce; Rugo, Hope S; Twelves, Chris; Im, Seock-Ah; Gómez-Pardo, Patricia; Schwartzberg, Lee S; Diéras, Veronique; Yardley, Denise A; Potter, David A; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Ha... Journal: Lancet oncology Issue: Volume 16:Issue 15(2015) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗